Compound name
BI-3406
Protein family
Guanine Nucleotide Exchange Factor
Target name
SOS1
Affinity biochemical (nM)
5
Affinity on-target cellular (nM)
24
CG-Set
Other targets set
Recommended Concentration
1 µM
Compound EUbOPEN ID
EUB0001729a
SMILES
COc1cc2nc(C)nc(N[C@H](C)c3cc(N)cc(C(F)(F)F)c3)c2cc1O[C@H]1CCOC1
InChIKey
XVFDNRYZXDHTHT-PXAZEXFGSA-N
NCBI gene ID
6654
UniProt ID
Q07889
Synonyms
SOS1
Mode of action
Inhibitor
Negative control
BI-0178
Affinity biochemical definition
IC50
Affinity biochemical assay type
Enzymatic assay (interaction of SOS1 with GDP-loaded KRAS)
Affinity Biochemical Source Knowledge
https://www.opnme.com/molecules/sos1-kras-inhibitor-bi-3406
Affinity biochemical relation
=
Affinity on-target cellular definition
IC50
Affinity on-target cellular assay type
Western blot assay (inhibition of pERK formation using KRAS mutant NCI-H358 cells)
Affinity on-target cellular source knowledge
https://www.opnme.com/molecules/sos1-kras-inhibitor-bi-3406
Affinity on-target cellular relation
=
Selectivity platform
Kinase panel (Invitrogen Lab)
Selectivity platform number of targets
326
Selectivity remarks
Screened at 1 µM, closest targets as % of control: BMPR2 (41%), PLK4 (38%), full screening data available on OpenMe website, https://www.opnme.com/molecules/sos1-kras-inhibitor-bi-3406;
Screened at 10 µM against 44 GPCRs, ion channels, and hydrolases (SafetyScreen44™), closest targets as % of control: ALPHA1A (antagonist, 7%), NA+/SITE2 (voltage-gated, 4%), full screening data available on OpenMe website, https://www.opnme.com/molecules/sos1-kras-inhibitor-bi-3406;
Screened at 10 µM against 44 GPCRs, ion channels, and hydrolases (SafetyScreen44™), closest targets as % of control: ALPHA1A (antagonist, 7%), NA+/SITE2 (voltage-gated, 4%), full screening data available on OpenMe website, https://www.opnme.com/molecules/sos1-kras-inhibitor-bi-3406;
Selectivity Source Knowledge
https://www.opnme.com/molecules/sos1-kras-inhibitor-bi-3406
Selectivity Number of Off-targets
0